Publicacions en col·laboració amb investigadors/es de Scripps Research Institute (10)

2024

  1. Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site

    Cell Host and Microbe, Vol. 32, Núm. 2, pp. 261-275.e4

2023

  1. Revealing the Specificity of Human H1 Influenza A Viruses to Complex N-Glycans

    JACS Au, Vol. 3, Núm. 3, pp. 868-878

2020

  1. Efficient Chemoenzymatic Synthesis of N-Glycans with a β1,4-Galactosylated Bisecting GlcNAc Motif

    ChemBioChem, Vol. 21, Núm. 22, pp. 3212-3215

2018

  1. Avenues to Characterize the Interactions of Extended N-Glycans with Proteins by NMR Spectroscopy: The Influenza Hemagglutinin Case

    Angewandte Chemie - International Edition, Vol. 57, Núm. 46, pp. 15051-15055

  2. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination

    Biochemical Pharmacology, Vol. 157, pp. 189-201

2014

  1. The extracellular entrance provides selectivity to serotonin 5-HT 7 receptor antagonists with antidepressant-like behavior in vivo

    Journal of Medicinal Chemistry, Vol. 57, Núm. 15, pp. 6879-6884

2011

  1. Development of non-peptide ligands of growth factor receptor-bound protein 2-src homology 2 domain using molecular modeling and NMR spectroscopy

    Journal of Medicinal Chemistry, Vol. 54, Núm. 4, pp. 1096-1100

2008

  1. Targeted disruption of the PME-1 gene causes loss of demethylated PP2A and perinatal lethality in mice

    PLoS ONE, Vol. 3, Núm. 7

2005

  1. Therapeutic perspectives of inhibitors of endocannabinoid degradation

    Current Drug Targets: CNS and Neurological Disorders, Vol. 4, Núm. 6, pp. 697-707

2004

  1. Comparison of anandamide transport in FAAH wild-type and knockout neurons: Evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake

    Biochemistry, Vol. 43, Núm. 25, pp. 8184-8190